Characteristics and efficacy of physical activity interventions to improve cardiometabolic and psychosocial outcomes in people living with HIV in sub-Saharan Africa: a protocol for a systematic review.
Cardiometabolic
HIV
People living with HIV
Physical activity
Sub-Saharan Africa
Systematic review
Journal
Systematic reviews
ISSN: 2046-4053
Titre abrégé: Syst Rev
Pays: England
ID NLM: 101580575
Informations de publication
Date de publication:
23 02 2023
23 02 2023
Historique:
received:
08
10
2021
accepted:
06
02
2023
entrez:
23
2
2023
pubmed:
24
2
2023
medline:
25
2
2023
Statut:
epublish
Résumé
Antiretroviral therapy (ART) has led to an increased lifespan for people living with HIV (PWH). This increased lifespan, coupled with the effects of HIV and adverse effects of ART have resulted in an increasing burden of cardiometabolic disease (CMD) among PWH. Physical activity (PA) has been proposed as an effective strategy to reduce the risk of developing cardiometabolic disease and other health complications in PWH. The aim of this paper is to review the characteristics and efficacy of PA interventions to improve cardiometabolic and psychosocial outcomes among PWH in sub-Saharan Africa. The review will follow the preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P). Literature searches will be conducted in PubMed, Web of Science (WoS), African Index Medicus, Cumulative Index to Nursing and Allied Health Literature (CINAHL), and Embase. Peer-reviewed publications will be included if they include adults (age 18 or older), PWH in sub-Saharan Africa, and a PA intervention to improve cardiometabolic outcomes and/or psychosocial outcomes. We will include randomized controlled trials and quasi-experimental study designs. Two independent reviewers will screen all abstracts and full-text articles. The study methodological quality (or bias) will be appraised using the Revised tool to assess risk of bias in randomized trials and the Downs and Black checklist. Certainty of evidence will be evaluated using the Grading of Recommendations Assessment, Development and Evaluation guidelines. Meta-analyses will be conducted if our results are adequate for meta-analysis. Outcomes will be analyzed as continuous or dichotomous and meta-analyses will be conducted using random effects models with Stata computer software. This review will identify and synthesize the current evidence regarding the characteristics and efficacy of PA interventions to improve cardiometabolic and psychosocial outcomes among PWH in sub-Saharan Africa. We also plan to identify the strengths and weaknesses of evaluated interventions. Based on the evidence, recommendations will be made to promote the design and further evaluate the most promising strategies to maximize the efficacy of PA interventions in improving cardiometabolic and psychosocial outcomes in PWH in sub-Saharan Africa. PROSPERO registration ID: CRD42021271937.
Sections du résumé
BACKGROUND
Antiretroviral therapy (ART) has led to an increased lifespan for people living with HIV (PWH). This increased lifespan, coupled with the effects of HIV and adverse effects of ART have resulted in an increasing burden of cardiometabolic disease (CMD) among PWH. Physical activity (PA) has been proposed as an effective strategy to reduce the risk of developing cardiometabolic disease and other health complications in PWH. The aim of this paper is to review the characteristics and efficacy of PA interventions to improve cardiometabolic and psychosocial outcomes among PWH in sub-Saharan Africa.
METHODS
The review will follow the preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P). Literature searches will be conducted in PubMed, Web of Science (WoS), African Index Medicus, Cumulative Index to Nursing and Allied Health Literature (CINAHL), and Embase. Peer-reviewed publications will be included if they include adults (age 18 or older), PWH in sub-Saharan Africa, and a PA intervention to improve cardiometabolic outcomes and/or psychosocial outcomes. We will include randomized controlled trials and quasi-experimental study designs. Two independent reviewers will screen all abstracts and full-text articles. The study methodological quality (or bias) will be appraised using the Revised tool to assess risk of bias in randomized trials and the Downs and Black checklist. Certainty of evidence will be evaluated using the Grading of Recommendations Assessment, Development and Evaluation guidelines. Meta-analyses will be conducted if our results are adequate for meta-analysis. Outcomes will be analyzed as continuous or dichotomous and meta-analyses will be conducted using random effects models with Stata computer software.
DISCUSSION
This review will identify and synthesize the current evidence regarding the characteristics and efficacy of PA interventions to improve cardiometabolic and psychosocial outcomes among PWH in sub-Saharan Africa. We also plan to identify the strengths and weaknesses of evaluated interventions. Based on the evidence, recommendations will be made to promote the design and further evaluate the most promising strategies to maximize the efficacy of PA interventions in improving cardiometabolic and psychosocial outcomes in PWH in sub-Saharan Africa.
SYSTEMATIC REVIEW REGISTRATION
PROSPERO registration ID: CRD42021271937.
Identifiants
pubmed: 36814348
doi: 10.1186/s13643-023-02186-5
pii: 10.1186/s13643-023-02186-5
pmc: PMC9948386
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
24Subventions
Organisme : Wellcome Trust
ID : 201433/A/16/A
Pays : United Kingdom
Informations de copyright
© 2023. The Author(s).
Références
J Gen Intern Med. 2008 May;23(5):588-94
pubmed: 18317847
AIDS Res Hum Retroviruses. 2008 Jan;24(1):15-23
pubmed: 18275343
J Epidemiol Community Health. 1998 Jun;52(6):377-84
pubmed: 9764259
J Psychosom Res. 2019 Nov;126:109823
pubmed: 31518734
J Community Health Nurs. 2017 Jan-Mar;34(1):21-31
pubmed: 28156143
Eur Rev Aging Phys Act. 2020 Apr 21;17:7
pubmed: 32336996
PLoS One. 2012;7(10):e47761
pubmed: 23082211
Vasc Health Risk Manag. 2014 Mar 18;10:129-37
pubmed: 24672244
J Clin Endocrinol Metab. 2008 Jun;93(6):2263-8
pubmed: 18334592
Nat Rev Immunol. 2011 Aug 05;11(9):607-15
pubmed: 21818123
PLoS One. 2021 Feb 5;16(2):e0246131
pubmed: 33544719
BMC Infect Dis. 2017 Jan 11;17(1):61
pubmed: 28077069
Ann Intern Med. 1997 Nov 1;127(9):820-6
pubmed: 9382404
J Clin Epidemiol. 2011 Apr;64(4):401-6
pubmed: 21208779
Curr HIV Res. 2012 Sep;10(6):487-97
pubmed: 22762420
BMC Infect Dis. 2017 Apr 12;17(1):268
pubmed: 28403830
AIDS Care. 2019 May;31(5):589-598
pubmed: 30712360
PLoS One. 2015 Sep 17;10(9):e0138066
pubmed: 26378794
BMC Infect Dis. 2016 Apr 26;16:182
pubmed: 27112335
J Clin Epidemiol. 2011 Dec;64(12):1294-302
pubmed: 21803546
Afr Health Sci. 2018 Jun;18(2):394-406
pubmed: 30602967
Chronic Illn. 2017 Dec;13(4):299-319
pubmed: 29119865
BMC Health Serv Res. 2015 Apr 08;15:143
pubmed: 25880727
J Sports Med Phys Fitness. 2017 May;57(5):678-684
pubmed: 27050662
ISRN AIDS. 2012 Aug 23;2012:960178
pubmed: 24052885
Am J Cardiol. 2016 Jan 15;117(2):214-20
pubmed: 26639041
J Sports Med Phys Fitness. 2017 May;57(5):685-694
pubmed: 27763579
Ann Behav Med. 2013 Aug;46(1):81-95
pubmed: 23512568
BMC Health Serv Res. 2017 Nov 15;17(1):737
pubmed: 29141626
Circulation. 2018 Sep 11;138(11):1100-1112
pubmed: 29967196
PLoS One. 2017 Jan 31;12(1):e0170893
pubmed: 28141867
Clin Infect Dis. 2021 Dec 6;73(11):2009-2022
pubmed: 34134131
Diabetes Care. 2004 Jul;27(7):1535-40
pubmed: 15220224
AIDS Res Hum Retroviruses. 2015 Dec;31(12):1250-6
pubmed: 26334673
J Clin Endocrinol Metab. 2008 Oct;93(10):3860-9
pubmed: 18628529
Transl Behav Med. 2019 Jan 1;9(1):147-157
pubmed: 29506209
Open AIDS J. 2015 Oct 20;9:89-95
pubmed: 26587077
Antivir Ther. 2016;21(3):237-45
pubmed: 26455521
BMJ. 2019 Aug 28;366:l4898
pubmed: 31462531
AIDS. 2018 Jul 1;32 Suppl 1:S43-S46
pubmed: 29952789
J Clin Epidemiol. 2009 Oct;62(10):e1-34
pubmed: 19631507
J Int Assoc Provid AIDS Care. 2018 Jan-Dec;17:2325958218759759
pubmed: 29529909
Infect Dis Rep. 2019 May 23;11(1):7925
pubmed: 31205641
Front Physiol. 2018 Dec 06;9:1641
pubmed: 30574090
Prog Cardiovasc Dis. 2020 Mar - Apr;63(2):178-183
pubmed: 32014512
Disabil Rehabil. 2018 Jul;40(14):1618-1629
pubmed: 28325087
Scand J Clin Lab Invest. 2011 Apr;71(2):101-7
pubmed: 21271804
J Exerc Rehabil. 2018 Aug 24;14(4):688-693
pubmed: 30276194
Niger J Clin Pract. 2014 Sep-Oct;17(5):543-8
pubmed: 25244260
PLoS One. 2015 Aug 19;10(8):e0134410
pubmed: 26287742
Lancet. 2008 Jul 26;372(9635):293-9
pubmed: 18657708
Int J Ment Health Syst. 2016 Mar 24;10:25
pubmed: 27014368
JAMA Netw Open. 2020 Jun 1;3(6):e207954
pubmed: 32539152
SAHARA J. 2013;10(3-4):113-8
pubmed: 24521093
BMC Infect Dis. 2019 Apr 29;19(1):359
pubmed: 31035959